Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants. | J Exp Med | 2022 | 35796685 | PubTator, text mining | PubMed |
| Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia. | Leukemia | 2022 | 35790817 | PubTator, text mining | PubMed |
| A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire. | Mol Biomed | 2022 | 35788448 | PubTator, text mining | PubMed |
| Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans. | J Exp Med | 2022 | 35776090 | PubTator, text mining | PubMed |
| Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth. | Antib Ther | 2022 | 35774245 | PubTator, text mining | PubMed |
| The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma. | Nat Commun | 2022 | 35768438 | PubTator, text mining | PubMed |
| Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism. | Immunity | 2022 | 35768001 | PubTator, text mining | PubMed |
| Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts. | Nat Immunol | 2022 | 35761085 | PubTator, text mining | PubMed |
| Human IgE mAbs identify major antigens of parasitic worm infection. | J Allergy Clin Immunol | 2022 | 35760390 | PubTator, text mining | PubMed |
| Primary Dural Mucosa-associated Lymphoid Tissue Lymphoma Mimicking Falx Meningioma: A Case Report. | NMC Case Rep J | 2022 | 35756189 | PubTator, text mining | PubMed |
| Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors. | Biomolecules | 2022 | 35740961 | PubTator, text mining | PubMed |
| CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation. | Noncoding RNA | 2022 | 35736639 | PubTator, text mining | PubMed |
| The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | 35732829 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing-based immunological feature analysis of a COVID-19 patient with recurrent positive SARS-CoV-2 RNA. | Chin Med J (Engl) | 2022 | 35730376 | PubTator, text mining | PubMed |
| Contribution of rare mutational outcomes to broadly neutralizing antibodies. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35713319 | PubTator, text mining | PubMed |
| Antibody repertoire sequencing analysis. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35713313 | PubTator, text mining | PubMed |
| Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2. | J Exp Med | 2022 | 35704748 | PubTator, text mining | PubMed |
| A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies. | MAbs | 2022 | 35699511 | PubTator, text mining | PubMed |
| Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma. | Blood Adv | 2022 | 35675515 | PubTator, text mining | PubMed |
| DNA Damage Response and Repair in Adaptive Immunity. | Front Cell Dev Biol | 2022 | 35663402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=19